Terms: = Colorectal cancer AND POLE, POLE1, 5426, FLJ21434, DKFZp434F222, ENSG00000177084
263 results:
1. Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer.
D'Agostino E; Mastrodomenico L; Ponzoni O; Baldessari C; Piombino C; Pipitone S; Giuseppa Vitale M; Sabbatini R; Dominici M; Toss A
Cancer Treat Rev; 2024 May; 126():102723. PubMed ID: 38555857
[TBL] [Abstract] [Full Text] [Related]
2. Multiomic molecular characterization of the response to combination immunotherapy in MSS/pMMR metastatic colorectal cancer.
Takei S; Tanaka Y; Lin YT; Koyama S; Fukuoka S; Hara H; Nakamura Y; Kuboki Y; Kotani D; Kojima T; Bando H; Mishima S; Ueno T; Kojima S; Wakabayashi M; Sakamoto N; Kojima M; Kuwata T; Yoshino T; Nishikawa H; Mano H; Endo I; Shitara K; Kawazoe A
J Immunother Cancer; 2024 Feb; 12(2):. PubMed ID: 38336371
[TBL] [Abstract] [Full Text] [Related]
3. Exploring Co-occurring pole Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor Mutagenicity.
Shah SM; Demidova EV; Ringenbach S; Faezov B; Andrake M; Gandhi A; Mur P; Viana-Errasti J; Xiu J; Swensen J; Valle L; Dunbrack RL; Hall MJ; Arora S
Cancer Res Commun; 2024 Jan; 4(1):213-225. PubMed ID: 38282550
[TBL] [Abstract] [Full Text] [Related]
4. Caecal malakoplakia: a rare mimic of malignancy.
Li Voon Chong J; Ali N
BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38262716
[TBL] [Abstract] [Full Text] [Related]
5. DNA polymerase ε and δ variants drive mutagenesis in polypurine tracts in human tumors.
Ostroverkhova D; Tyryshkin K; Beach AK; Moore EA; Masoudi-Sobhanzadeh Y; Barbari SR; Rogozin IB; Shaitan KV; Panchenko AR; Shcherbakova PV
Cell Rep; 2024 Jan; 43(1):113655. PubMed ID: 38219146
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of mismatch-repair and microsatellite-instability status in a Chinese colorectal cancer Cohort.
Zhang P; Wang A; Bian C; Zhang J; Jiang C; Zhou H
Asian J Surg; 2024 Feb; 47(2):959-967. PubMed ID: 38185557
[TBL] [Abstract] [Full Text] [Related]
7. A Comprehensive Study of Heterogeneous Mismatch Repair Expression in Solid Tumors Reveals Different Immunohistochemical Patterns and Distinct Genetic Mechanisms.
Wang J; Zhang Z; Cai Y; Lu J; Zhang H; Pang J; Wu H; Liang Z
Am J Surg Pathol; 2024 Apr; 48(4):417-425. PubMed ID: 37997470
[TBL] [Abstract] [Full Text] [Related]
8. Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial.
André T; Berton D; Curigliano G; Sabatier R; Tinker AV; Oaknin A; Ellard S; de Braud F; Arkenau HT; Trigo J; Gravina A; Kristeleit R; Moreno V; Abdeddaim C; Vano YA; Samouëlian V; Miller R; Boni V; Torres AA; Gilbert L; Brown J; Dewal N; Dabrowski C; Antony G; Zografos E; Veneris J; Banerjee S
JAMA Netw Open; 2023 Nov; 6(11):e2341165. PubMed ID: 37917058
[TBL] [Abstract] [Full Text] [Related]
9. Exploring the basis of heterogeneity of cancer aggressiveness among the mutated pole variants.
Selves J; de Castro E Gloria H; Brunac AC; Saffi J; Guimbaud R; Brousset P; Hoffmann JS
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37891003
[TBL] [Abstract] [Full Text] [Related]
10. Adoption of Universal Testing in Endometrial cancers for Microsatellite Instability Using Next-Generation Sequencing.
Rodriguez IV; Strickland S; Wells D; Manhardt E; Konnick EQ; Garcia R; Swisher E; Kilgore M; Norquist B
JCO Precis Oncol; 2023 Sep; 7():e2300033. PubMed ID: 37856764
[TBL] [Abstract] [Full Text] [Related]
11. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256
[No Abstract] [Full Text] [Related]
12. Recommendations for the classification of germline variants in the exonuclease domain of pole and POLD1.
Mur P; Viana-Errasti J; García-Mulero S; Magraner-Pardo L; Muñoz IG; Pons T; Capellá G; Pineda M; Feliubadaló L; Valle L
Genome Med; 2023 Oct; 15(1):85. PubMed ID: 37848928
[TBL] [Abstract] [Full Text] [Related]
13. Germline de novo mutations in families with Mendelian cancer syndromes caused by defects in DNA repair.
Sherwood K; Ward JC; Soriano I; Martin L; Campbell A; Rahbari R; Kafetzopoulos I; Sproul D; Green A; Sampson JR; Donaldson A; Ong KR; Heinimann K; Nielsen M; Thomas H; Latchford A; Palles C; Tomlinson I
Nat Commun; 2023 Jun; 14(1):3636. PubMed ID: 37336879
[TBL] [Abstract] [Full Text] [Related]
14. The role of immune checkpoint inhibitors for patients with advanced stage microsatellite stable colorectal cancer and high tumor mutation burden: quantity or quality?
Vegivinti CTR; Gonzales Gomez C; Syed M; Ferrell M; Cheng S; Singhi A; Saeed A; Sahin IH
Expert Opin Biol Ther; 2023; 23(7):595-601. PubMed ID: 37318031
[TBL] [Abstract] [Full Text] [Related]
15. Effect of real-time computer-aided detection of colorectal adenoma in routine colonoscopy (COLO-GENIUS): a single-centre randomised controlled trial.
Karsenti D; Tharsis G; Perrot B; Cattan P; Percie du Sert A; Venezia F; Zrihen E; Gillet A; Lab JP; Tordjman G; Cavicchi M
Lancet Gastroenterol Hepatol; 2023 Aug; 8(8):726-734. PubMed ID: 37269872
[TBL] [Abstract] [Full Text] [Related]
16. pole-Mutant Colon cancer Treated with PD-1 Blockade Showing Clearance of Circulating Tumor DNA and Prolonged Disease-Free Interval.
Bikhchandani M; Amersi F; Hendifar A; Gangi A; Osipov A; Zaghiyan K; Atkins K; Cho M; Aguirre F; Hazelett D; Alvarez R; Zhou L; Hitchins M; Gong J
Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239414
[TBL] [Abstract] [Full Text] [Related]
17. Genomic landscape and its prognostic significance in stage III colorectal cancer: JCOG1506A1, an ancillary of JCOG0910.
Shida D; Kuchiba A; Shibata T; Hamaguchi T; Yamasaki S; Ito M; Kobatake T; Tonooka T; Masaki T; Shiozawa M; Takii Y; Uetake H; Okamura S; Ojima H; Kazama S; Takeyama H; Kanato K; Shimada Y; Murakami Y; Kanemitsu Y
Cancer Sci; 2023 Aug; 114(8):3352-3363. PubMed ID: 37189003
[TBL] [Abstract] [Full Text] [Related]
18. Spatial resolution of cellular senescence dynamics in human colorectal liver metastasis.
Garbarino O; Lambroia L; Basso G; Marrella V; Franceschini B; Soldani C; Pasqualini F; Giuliano D; Costa G; Peano C; Barbarossa D; Annarita D; Salvati A; Terracciano L; Torzilli G; Donadon M; Faggioli F
Aging Cell; 2023 Jul; 22(7):e13853. PubMed ID: 37157887
[TBL] [Abstract] [Full Text] [Related]
19. Lynch syndrome: influence of additional susceptibility variants on cancer risk.
Vibert R; Hasnaoui J; Perrier A; Lefebvre A; Colas C; Dhooge M; Basset N; Chansavang A; Desseignes C; Duval A; Farelly S; Hamzaoui N; Laurent-Puig P; Metras J; Moliere D; Muleris M; Netter J; Touat M; Bielle F; Labreche K; Nicolle R; Perkins G; Warcoin M; Coulet F; Benusiglio PR
Eur J Hum Genet; 2023 Sep; 31(9):1078-1082. PubMed ID: 37088804
[TBL] [Abstract] [Full Text] [Related]
20. Immune Checkpoint Inhibitors in pMMR/MSS colorectal cancer.
El Hajj J; Reddy S; Verma N; Huang EH; Kazmi SM
J Gastrointest Cancer; 2023 Dec; 54(4):1017-1030. PubMed ID: 37009977
[TBL] [Abstract] [Full Text] [Related]
[Next]
